Latest News

National Academies issue guidance for childhood COVID-19 vaccines


 

Key points

The key strategies highlighted for communicating with parents include the following:

  • Emphasizing safety and efficacy: Parents should be informed about the ongoing research and clinical trials that will answer more questions about the vaccine and that there is continued monitoring for any safety risks. Pointing to the safety data from the clinical trials for 12- to 17-year-olds, and the lack of serious adverse events from the vaccine in this age group may help alleviate concerns.
  • CalibriEncouraging parents to talk with a primary care provider: Research shows that parents trust family physicians and other health care practitioners to provide them with accurate information about vaccines. Local, state, and national leaders can provide messaging templates and other resources to health care professionals who are engaged in these conversations.
  • Leveraging social networks to influence parents’ vaccination decisions: Parents are influenced by their social network connections. It is important to engage these networks, especially with members of their community who are considered trustworthy and influential. Social networks may also be very diverse, and include family members, friends, coworkers, social media, and members of their religious community.

While the guidance states that different groups of parents will require different messaging, they suggest that communication can begin with a focus on the things that vaccination can accomplish. In addition to preventing infection with COVID-19, it will allow children to attend school in person and participate in extracurricular activities such as sports, without risking their health. “One thing I’ve learned over several years of working with vaccine-hesitant parents is that you have to tailor each approach to the individual,” said Dr. Ameenuddin. “Different people have different concerns, and first and foremost, it’s important to listen.”

For some parents, emphasizing that the more people that can be vaccinated and the sooner it can be done, the sooner everyone can return to a normal life is a good approach, she added. “I think it’s important to emphasize both the individual and communal benefits of vaccines, but that won’t necessarily reach every person with concerns. I think it’s important to find out what is most important to individuals and work from there to find a way to connect with that family to encourage vaccination.”

Dr. Ameenuddin has no disclosures.

Pages

Recommended Reading

FDA advisors vote to recommend Moderna boosters
MDedge Pediatrics
Childhood vaccination rates up since early pandemic, but few are up to date
MDedge Pediatrics
Pandemic survey: Forty-six percent of pediatric headache patients got worse
MDedge Pediatrics
Pandemic adds more weight to burden of obesity in children
MDedge Pediatrics
Mixing COVID vaccine boosters may be better option: Study
MDedge Pediatrics
FDA panel backs second dose for Johnson & Johnson vaccine recipients
MDedge Pediatrics
Biomarkers may indicate severity of COVID in children
MDedge Pediatrics
Paper linking COVID-19 vaccines to myocarditis is temporarily removed without explanation
MDedge Pediatrics
States can reserve COVID shots for kids 5-11 this week
MDedge Pediatrics
PA defends against license suspension for COVID treatment
MDedge Pediatrics